CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell...
Phase 2
Aurora, Colorado, United States and 47 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Aurora, Colorado, United States and 123 other locations
over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non...
Phase 1
Aurora, Colorado, United States and 36 other locations
with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...
Phase 2
Aurora, Colorado, United States and 2 other locations
NSCLC comprises of approximately 84 percent (%) of all lung cancers and is often diagnosed at advanced stage due to poor prognosis....
Phase 2
Lone Tree, Colorado, United States and 57 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Aurora, Colorado, United States and 122 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Aurora, Colorado, United States and 230 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...
Phase 1
Aurora, Colorado, United States and 25 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Aurora, Colorado, United States and 252 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Lone Tree, Colorado, United States and 227 other locations
Clinical trials
Research sites
Resources
Legal